Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Primary outcome(s): Response rate, Time to Treatment failure, Adverse events rate, Progression free survival, Overall survival
创建时间：
2008-09-15
